BioForm sees Q4 loss widen
This article was originally published in Clinica
Medical aesthetics firm BioForm Medical was hit by an $11.2m one-time charge, related to its acquisition of Advanced Cosmetic Intervention in April 2008, which led to a four-fold increase in net loss for the fourth quarter. Increased operating costs from the expansion of its sales and marketing network, clinical programmes, and other general administrative expenses also contributed to the net loss, which widened from $4.9m to $20m. The San Mateo, California firm saw sales grow by 8% to $16.7m.